Deargen and KMEDIhub conducted co-developemnt for new drug discovery AI platform.
Read More
Technical & News Articles about Deargen
Deargen and KMEDIhub conducted co-developemnt for new drug discovery AI platform.
Read More디어젠과 케이메디허브가 인공지능 신약개발 플랫폼 개발 공동연구 협약을 체결했다.
Read MoreDeargen announced on 6th that they agreed to collaborate with JW pharmaceutical to develop innovative new drugs via Deargen’s AI model.
Read More디어젠은 JW중외제약과 AI 기반의 혁신신약 개발을 위한 공동연구 협약을 체결했다고 6일 밝혔다.
Read More인공지능 플랫폼 고도화를 위한 양질의 데이터 생산기지 역할, 디어젠만의 인공지능 융합 신약개발플랫폼(DEARGEN iDears) 완성
Read MoreDeargen has completed the end-to-end AI drug development platform ‘DEARGEN iDeas” to serve as a high-quality data productino for advancing its platform.
Read MoreInhwan Bae, CDO of Deargen, said through the iDear Center that Deargen will enhance the preclinical pipeline and be in full swing of innovative drug development.
Read More배인환 CDO 인터뷰, iDear Center를 통한 전임상 파이프라인 강화, 혁신 신약 개발 본격화
Read More배영철 CBO 인터뷰, 아미노산 서열 분석으로 혁신신약 후보물질 발굴, 각 제약사에 맞는 플랫폼 판매도 계획
Read MoreOne of the most significant business models for AI drug development companies is collaborating with global companies..
Read More